Novan Inc
NOVN
Common Stock
$0.09
Sector: Health Care
Industry: Pharmaceuticals
Sub-Industry: Pharmaceuticals
|
|
|
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
(Diluted) Earnings Per Share | -$1.74 | -$2.96 | -$11.57 | -$4.91 | -$22.91 |
Sales/Revenue | $2.96 M | $4.92 M | $4.90 M | $5.99 M | $2.65 M |
Sales Growth | -39.88% | 0.49% | -18.28% | 126.42% | 0.00% |
Gross Margin | +88.37 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income | -$29.69 M | -$29.29 M | -$30.38 M | -$12.67 M | -$36.62 M |
Net Income Growth | -1.36% | 3.57% | -139.70% | 65.39% | 0.00% |
Net Margin | -1003.79 | 0.00 | 0.00 | 0.00 | 0.00 |
EBITDA | -$29.46 M | -$25.00 M | -$27.78 M | -$26.57 M | -$33.46 M |
Cost of Goods Sold (incl D&A) | $0.34 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Cost of Goods Sold (excl D&A) | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Cost of Goods Growth | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Research & Development | $20.42 M | $19.81 M | $25.17 M | $23.05 M | $25.21 M |
Other SG&A Expenses | $0.00 M | $10.10 M | $7.50 M | $9.51 M | $10.90 M |
Interest Expense | $0.00 M | $0.00 M | $0.00 M | $1.05 M | $1.05 M |
Income Tax | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | |
---|---|---|---|---|
(Diluted) Earnings Per Share | -$0.44 | -$0.71 | -$0.44 | -$0.34 |
Sales/Revenue | $6.16 M | $1.93 M | $0.66 M | $0.74 M |
Sales Growth | 219.40% | 194.35% | -11.13% | -1.34% |
Gross Margin | +88.37 | 0.00 | 0.00 | 0.00 |
Net Income | -$8.88 M | -$13.38 M | -$8.23 M | -$6.48 M |
Net Income Growth | 33.65% | -62.52% | -26.97% | -7.65% |
Net Margin | -1003.79 | 0.00 | 0.00 | 0.00 |
EBITDA | -$7.95 M | -$13.01 M | -$7.99 M | -$6.38 M |
Cost of Goods Sold (incl D&A) | $3.41 M | $0.42 M | $0.10 M | $0.00 M |
Cost of Goods Sold (excl D&A) | $2.61 M | $0.21 M | $0.00 M | $0.00 M |
Cost of Goods Growth | 703.54% | 315.69% | 0.00% | 0.00% |
Research & Development | $3.14 M | $4.83 M | $4.49 M | $4.25 M |
Other SG&A Expenses | $0.00 M | $0.00 M | $0.00 M | $2.87 M |
Interest Expense | $0.61 M | $0.13 M | $0.00 M | $0.00 M |
Income Tax | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Net Property and Plant Equipment | $13.89 M | $2.41 M | $12.34 M | $15.87 M | $16.62 M |
Cash and Short-Term Investment | $47.09 M | $35.88 M | $13.71 M | $8.19 M | $2.52 M |
Cash and Short-Term Investment Growth | 31.23% | 161.68% | 67.33% | 224.64% | 0.00% |
Long Term Debt | $3.61 M | $0.48 M | $5.10 M | $8.01 M | $8.02 M |
Net Total Accounts Receivable | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Total Accounts Receiveable | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Total Accounts Payable | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Total Assets | $68.96 M | $46.83 M | $29.10 M | $26.36 M | $21.13 M |
Total Assets Growth | 47.26% | 60.94% | 10.37% | 24.74% | 0.00% |
Inventories | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Finished Goods | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Short Term Debt | $0.00 M | $0.48 M | $1.16 M | $0.01 M | $0.01 M |
Total Liabilities | $50.64 M | $43.85 M | $51.38 M | $21.16 M | $22.85 M |
2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | |
---|---|---|---|---|---|
Net Property and Plant Equipment | $16.04 M | $15.53 M | $13.89 M | $11.53 M | $10.09 M |
Cash and Short-Term Investment | $37.30 M | $35.49 M | $47.09 M | $59.96 M | $65.80 M |
Cash and Short-Term Investment Growth | 5.10% | -24.62% | -21.47% | -8.88% | 0.00% |
Long Term Debt | $20.20 M | $20.40 M | $3.61 M | $2.97 M | $3.10 M |
Net Total Accounts Receivable | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Total Accounts Receiveable | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Total Accounts Payable | $0.00 M | $0.00 M | $0.00 M | $0.00 M | $0.00 M |
Total Assets | $114.39 M | $112.05 M | $68.96 M | $73.89 M | $79.72 M |
Total Assets Growth | 2.09% | 62.48% | -6.67% | -7.31% | 0.00% |
Inventories | $2.75 M | $2.71 M | $0.00 M | $0.00 M | $0.00 M |
Finished Goods | $1.57 M | $1.48 M | $0.00 M | $0.00 M | $0.00 M |
Short Term Debt | $0.23 M | $0.23 M | $0.00 M | $0.00 M | $0.00 M |
Total Liabilities | $102.14 M | $106.17 M | $50.64 M | $47.70 M | $47.39 M |
Expiration Date | Call To Put Ratio | Open Money on Chain |
---|
Quarter | Amount | Yield |
---|
|
|